These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10861587)

  • 1. A self-complementary, self-assembling microsphere system: application for intravenous delivery of the antiepileptic and neuroprotectant compound felbamate.
    Lian H; Steiner SS; Sofia RD; Woodhead JH; Wolf HH; White HS; Shen GS; Rhodes CA; McCabe RT
    J Pharm Sci; 2000 Jul; 89(7):867-75. PubMed ID: 10861587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam and felbamate interact both pharmacodynamically and pharmacokinetically: an isobolographic analysis in the mouse maximal electroshock model.
    Luszczki JJ; Andres-Mach MM; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2007 Apr; 48(4):806-15. PubMed ID: 17284299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of felbamate with several other antiepileptic drugs against seizures induced by maximal electroshock in mice.
    Gordon R; Gels M; Wichmann J; Diamantis W; Sofia RD
    Epilepsia; 1993; 34(2):367-71. PubMed ID: 8453946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Felbamate: successful development of a new compound for the treatment of epilepsy.
    Schmidt D
    Epilepsia; 1993; 34 Suppl 7():S30-3. PubMed ID: 8243376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.
    McCabe RT; Wasterlain CG; Kucharczyk N; Sofia RD; Vogel JR
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1248-52. PubMed ID: 8383742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of some convulsant agents on the protective activity of a novel antiepileptic drug, felbamate, against maximal electroshock in mice.
    Swiader M; Gasior M; Wielosz M; Czuczwar SJ
    Pol J Pharmacol; 2003; 55(4):649-53. PubMed ID: 14581726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Felbamate in experimental model of status epilepticus.
    Mazarati AM; Baldwin RA; Sofia RD; Wasterain CG
    Epilepsia; 2000 Feb; 41(2):123-7. PubMed ID: 10691107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of felbamate after kainic acid-induced status epilepticus.
    Chronopoulos A; Stafstrom C; Thurber S; Hyde P; Mikati M; Holmes GL
    Epilepsia; 1993; 34(2):359-66. PubMed ID: 8453945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the interaction between felbamate and valproate against seizures induced by 4-aminopyridine and pentylenetetrazole in mice beneficial?
    Cuadrado A; Amat G; Armijo JA
    Pharmacol Res; 2003 Aug; 48(2):183-92. PubMed ID: 12798671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological actions of felbamate on rat striatal neurones.
    Pisani A; Stefani A; Siniscalchi A; Mercuri NB; Bernardi G; Calabresi P
    Br J Pharmacol; 1995 Oct; 116(3):2053-61. PubMed ID: 8640345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between lamotrigine and felbamate in the maximal electroshock-induced seizures in mice: an isobolographic analysis.
    Luszczki JJ; Czuczwar SJ
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):133-42. PubMed ID: 15695057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of chronic felbamate administration on anticonvulsant activity and hepatic drug-metabolizing enzymes in mice and rats.
    Swinyard EA; Woodhead JH; Franklin MR; Sofia RD; Kupferberg HJ
    Epilepsia; 1987; 28(3):295-300. PubMed ID: 3107974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsy.
    Sachdeo R; Narang-Sachdeo SK; Shumaker RC; Perhach JL; Lyness WH; Rosenberg A
    Epilepsia; 1997 Aug; 38(8):887-92. PubMed ID: 9579889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isobolographic and subthreshold analysis of interactions among felbamate and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice.
    Borowicz KK; Luszczki JJ; Czuczwar SJ
    Epilepsia; 2004 Oct; 45(10):1176-83. PubMed ID: 15461671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Felbamate monotherapy has stimulant-like effects in patients with epilepsy.
    Ketter TA; Malow BA; Flamini R; Ko D; White SR; Post RM; Theodore WH
    Epilepsy Res; 1996 Mar; 23(2):129-37. PubMed ID: 8964274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic and pharmacokinetic interaction studies of loreclezole with felbamate, lamotrigine, topiramate, and oxcarbazepine in the mouse maximal electroshock seizure model.
    Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2005 Mar; 46(3):344-55. PubMed ID: 15730531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Felbamate in the treatment of Lennox-Gastaut syndrome.
    Jensen PK
    Epilepsia; 1994; 35 Suppl 5():S54-7. PubMed ID: 8039473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical profile of combinations of some second-generation antiepileptic drugs: an isobolographic analysis.
    Luszczki JJ; Czuczwar SJ
    Epilepsia; 2004 Aug; 45(8):895-907. PubMed ID: 15270754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of the EEG paroxysmal pattern during felbamate therapy in Lennox-Gastaut syndrome: a case report.
    Marciani MG; Spanedda F; Placidi F; Bassetti MA; Romigi A; Mattia D
    Int J Neurosci; 1998 Sep; 95(3-4):247-53. PubMed ID: 9777442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of felbamate on phenytoin and carbamazepine serum concentrations.
    Graves NM; Holmes GB; Fuerst RH; Leppik IE
    Epilepsia; 1989; 30(2):225-9. PubMed ID: 2647472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.